Anita Mazloom, MD
Hematology & Oncology · Mobile, ALNPI 1033607858
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 56 manufacturers reported payments, led by Sanofi at 33.3% of the total. 2025 is the largest year on record at $14,333, more than ten times the $50 reported in 2021.
Across 407 payments — averaging $48.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$7K
- AstraZeneca$2K
- Pfizer$2K
- Adaptive Biotechnologies Corporation$1K
- Bristol Myers Squibb$842
- Novartis$833
- plus $6K from 50 others
Across 5 payments — averaging $86,800 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$377K
- Eli Lilly$57K
What the payments were for
- Consulting fees$9,40048%
- Speaking & faculty fees$1101%
- Travel & lodging$1,6258%
- Food & beverage$8,15641%
- Education$3862%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,677 in reported general payments places this provider in the 75th percentile of 177 hematology & oncology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Mobile
- Sherri ArledgeMobile$19K
- Daniel CameronMobile$17K
- Jose Galeas SorianoMobile$17K
- Michael MeshadMobile$14K
- Amitkumar MehtaBirmingham$683K
- Pankit VachhaniBirmingham$545K
- Luciano CostaBirmingham$409K
- Khaleel AshrafBirmingham$379K
- Michael BirrerBirmingham$302K
- Rudolph NavariBirmingham$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.